Idris passes a critical milestone on the path to the clinic by successfully conducting animal trials on both safety and efficacy. This proves the viability of the concept and paves the way for clinical trials.
We’re raising capital to prepare the way for our first clinical trials. We still have room for a few informals or smaller funds.
-tickets for informals start at €25K, for funds at €250k.
-convertible loan, converts upon larger round in Q4-'23
-25% discount on valuation for larger round
2019
We’re always open to collaborations, such as our ongoing eurostarsTM project, where we were ranked 1st out of all the applications in 2019 call 1.